UPDATED Jun 30, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 205.60 | 0.4% | 137.1% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.61 | -3.6% | 27.8% | SEK 436.6m | SEK 2.20 | PS4.7x | E90.4% | n/a | Tech | ||
YUBICO | SEK 226.50 | -2.2% | 130.2% | SEK 19.5b | SEK 265.00 | PE117.8x | E43.8% | n/a | Software | ||
YIELD | SEK 2.49 | 1.6% | -66.5% | SEK 142.6m | SEK 9.00 | PB1.7x | E103.4% | n/a | Diversified Financials | ||
SILEON | SEK 0.56 | -6.7% | -87.9% | SEK 28.4m | n/a | PB1.8x | E109.3% | n/a | Software | ||
CTT | SEK 323.00 | -7.4% | 52.4% | SEK 4.0b | n/a | PE39.7x | E21.6% | 1.7% | Capital Goods | ||
BIOA B | SEK 228.80 | 5.9% | -18.9% | SEK 20.2b | SEK 368.00 | PS80.1x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 0.52 | 8.6% | -40.9% | SEK 19.3m | n/a | PB0.3x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.75 | 5.8% | -59.5% | SEK 231.2m | SEK 7.90 | PS31.7x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.56 | -4.8% | -28.7% | SEK 276.9m | SEK 3.65 | PS2.9x | E104.9% | n/a | Tech | ||
ORGC | SEK 3.84 | 1.3% | -17.4% | SEK 376.8m | SEK 3.00 | PS2.7x | E103.3% | n/a | Materials | ||
CRAD B | SEK 43.60 | 4.7% | 59.1% | SEK 1.5b | SEK 56.00 | PE30.4x | E30.4% | n/a | Healthcare | ||
ORT B | SEK 8.38 | 2.2% | 13.6% | SEK 310.8m | SEK 18.00 | PS4.9x | E62.8% | n/a | Healthcare | ||
MIDS | SEK 1.84 | 0.7% | -31.3% | SEK 386.3m | SEK 2.80 | PS6x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 7.20 | 3.6% | -36.3% | SEK 212.4m | SEK 17.25 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.44 | 10.3% | -37.0% | SEK 57.1m | SEK 1.00 | PB2x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
EGTX | SEK 4.67 | -25.5% | 8.6% | SEK 1.4b | SEK 13.30 | PS21.7x | E99.0% | n/a | Pharmaceuticals & Biotech | ||
QLIRO | SEK 23.00 | 6.7% | -3.8% | SEK 438.7m | SEK 21.00 | PE68.5x | E71.9% | n/a | Diversified Financials | ||
FNOX | SEK 63.98 | 3.5% | 0.5% | SEK 39.0b | SEK 73.78 | PE63.7x | E21.1% | 0.3% | Software | ||
NIUTEC | SEK 6.74 | 7.0% | -40.7% | SEK 133.9m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
NAVIGO STAM | SEK 4.07 | -7.9% | n/a | SEK 519.1m | n/a | PE658.2x | E77.4% | n/a | Diversified Financials | ||
ASAI | SEK 0.56 | -6.7% | -52.4% | SEK 207.1m | n/a | PS2.4x | E66.6% | n/a | Software | ||
LIME | SEK 350.00 | 6.7% | 28.0% | SEK 4.6b | SEK 353.33 | PE54x | E21.5% | 1.0% | Software |